IP Library › Assignment 029295/0674
Patent Assignment
Reel/Frame 029295/0674

Assignment of Assignor's Interest

Recorded: 2012-11-14 Pages: 2
Assignor
GRADALIS, INC.
Executed: 2012-11-12
Assignee
BRUNICARDI, F. CHARLES
1060 GLENHAVEN DRIVE, PACIFIC PALISADES, CALIFORNIA, 90272
Covered Property (1)
Novel Therapeutic Rna Interference Technology Targeted to the Pdx-1 Oncogene in Pdx-1 Expressing Neuroendocrine Tumors
Patent: 8,361,983 →
Application: 12/913,515 →
Publication: US 2011/0117183
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 15, 2010
From: NEMUNAITIS, JOHN; RAO, DONALD; BRUNICARDI, F. CHARLES
To: GRADALIS, INC.
Reel/Frame 025506/0253 →
Assignment of Assignor's Interest Nov 30, 2012
From: BRUNICARDI, F. CHARLES
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 029385/0753 →
Assignment of Assignor's Interest May 6, 2015
From: GRADALIS, INC.
To: STRIKE BIO, INC.
Reel/Frame 035603/0731 →
Merger May 3, 2018
From: STRIKE BIO, INC.
To: GRADALIS, INC.
Reel/Frame 045709/0406 →
Patent Security Agreement Dec 20, 2019
From: GRADALIS, INC.
To: HC INNOVATIVE PARTNERS, LP, AS COLLATERAL AGENT
Reel/Frame 051396/0366 →